| Schedule of the components of the calculations of basic and diluted earnings per share |
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
September 30,
|
|
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
Net loss
|
$
|
(10,325,464)
|
|
$
|
(6,290,546)
|
|
$
|
(23,388,120)
|
|
$
|
(20,286,414)
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding
|
37,977,052
|
|
22,676,114
|
|
33,107,175
|
|
17,441,767
|
|
| Schedule of potential dilutive common shares |
|
|
At September 30,
|
|
|
2012
|
|
2011
|
|
Stock options outstanding
|
1,999,521
|
|
1,344,665
|
|
Unvested restricted stock
|
|
275,262
|
|
408,388
|
|
Common stock warrants (1)
|
9,421,008
|
|
7,128,563
|
|
Number of dilutive potential common shares
|
11,695,791
|
|
8,881,616
|
|
(1)
|
On May 31, 2011, the Company granted 7,128,563 warrants as part of an underwritten public offering. As a result of the March 28 and 29, 2012 public offerings described in Note 5, the number of warrants increased to 9,421,008.
|
|